Literature DB >> 6843686

Murine lymphoma cells possess blood group Tn-, T-, N-, M- and S-active substances.

G F Springer, P R Desai, H Tegtmeyer, V Schirmacher, R Cheingsong-Popov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6843686     DOI： 10.1007/bf00365514

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN： 0028-1042


× No keyword cloud information.
  15 in total

1.  Blood group MN specific substances and precursors in normal and malignant human breast tissues.

Authors:  G F Springer; P R Desai; I Banatwala
Journal:  Naturwissenschaften       Date:  1974-10

2.  Human blood groups M-, N-, T-, and Tn-specific substances in lipidic extracts of line 10 hepatocarcinoma of strain 2 guinea pigs.

Authors:  G F Springer; J L Cantrell; P R Desai; H Tegtmeyer
Journal:  Clin Immunol Immunopathol       Date:  1982-01

Review 3.  Cross-reacting carcinoma-associated antigens with blood group and precursor specificities.

Authors:  G F Springer; P R Desai
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

4.  Biosynthesis of human blood group T-, N- and M-specific immunodeterminants on human erythrocyte antigens.

Authors:  P R Desai; G F Springer
Journal:  J Immunogenet       Date:  1979-12

5.  Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variant.

Authors:  P Altevogt; J T Kurnick; A K Kimura; K Bosslet; V Schirrmacher
Journal:  Eur J Immunol       Date:  1982-04       Impact factor: 5.532

6.  Decreased levels of circulating lytic anti-T in the serum of patients with metastatic gastrointestinal cancer: a correlation with disease burden.

Authors:  J Bray; G D MacLean; F J Dusel; T A McPherson
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

7.  Blood group precursor T-antigen expression in human urinary bladder carcinoma.

Authors:  J S Coon; R S Weinstein; J L Summers
Journal:  Am J Clin Pathol       Date:  1982-06       Impact factor: 2.493

8.  Anti-T antibody in malignant melanoma patients. Influence of response and survival following chemotherapy--changes in serum levels following C parvum, BCG immunization.

Authors:  N Thatcher; K Hashmi; J Chang; R Swindell; D Crowther
Journal:  Cancer       Date:  1980-09-15       Impact factor: 6.860

9.  Heterophile antibodies, immunoglobulin levels, and the evaluation on anti-T activity in cancer patients and controls.

Authors:  G H Vos; P Brain
Journal:  S Afr Med J       Date:  1981-07-25

10.  Hepatocyte-tumor cell interaction in vitro. I. Conditions for rosette formation and inhibition by anti-H-2 antibody.

Authors:  V Schirrmacher; R Cheingsong-Popov; H Arnheiter
Journal:  J Exp Med       Date:  1980-04-01       Impact factor: 14.307
View more
  2 in total

1.  Inhibition of liver tumor cell colonization in two animal tumor models by lectin blocking with D-galactose or arabinogalactan.

Authors:  J Beuth; H L Ko; V Schirrmacher; G Uhlenbruck; G Pulverer
Journal:  Clin Exp Metastasis       Date:  1988 Mar-Apr       Impact factor: 5.150

2.  Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose.

Authors:  J Beuth; H L Ko; K Oette; G Pulverer; K Roszkowski; G Uhlenbruck
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.